Hybe Co., Ltd., the managing agency of the BTS superstar K-pop boy group, accused the executives of one of its sub-labels, ADOR, of breach of trust. The company alleged that its affiliate's chief executive officer, Min Hee Jin, plans to make ADOR, which manages the NewJeans girl group, an independent label.
Based on the reports, Hybe supposedly learned about the plot after launching an audit into the sub-label on April 22. Now, the company is preparing to file complaints against the executives involved. It would charge them with breach of trust and other offenses.
A Call to Resign and Evidence
In a statement sent to CNBC, Hybe said it had already requested Min step down as ADOR's chief. The entertainment company further told the publication it acquired substantial evidence against the CEO related to her alleged plans to take control of ADOR.
Hybe said the proofs in its hands include detailed discussions that Min ordered the sub-label's management to find ways to pressure Hybe into selling the label's shares. The company also sent a screenshot of the alleged message between Min and the vice CEO of ADOR.
Hybe Reports Min Hee Jin to Police
Hybe said earlier that it would report Min Hee Jin to the police as it has found enough evidence to charge her with several offenses. According to Korea Joongang Daily, the company's action came three days after it started the audit on ADOR.
With everything Hybe said against the ADOR chief, she denied every offense pinned against her. She also accused the company of copying the concept of NewJeans and applying it to a girl group of another Hybe sub-label.
Meanwhile, the company troubles happened when NewJeans was preparing to make a comeback. Hybe's CEO, Park Ji Won, apologized and said they would ensure their artists were not affected by the issues.
"We promise to prioritize the mental recovery and emotional stability of our artists, who are the most precious assets in K-pop, now that the situation has settled for the time being," he said.
Photo by: Hybe Website


Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FDA Approves Mitapivat for Anemia in Thalassemia Patients
George Clooney Criticizes Trump’s Tariff Threat, Calls for Film Tax Incentives
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Disney Investors Demand Records Over Jimmy Kimmel Suspension Controversy
Disney’s ABC Pulls Jimmy Kimmel Live! After Controversial Remarks on Charlie Kirk Killing
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Pulp are back and more wistfully Britpop than before
Google and NBCUniversal Strike Multi-Year Deal to Keep NBC Shows on YouTube TV
Trump-Inspired Cantonese Opera Brings Laughter and Political Satire to Hong Kong
Squid Game Finale Boosts Netflix Earnings, But Guidance Disappoints Investors
The quest to extend human life is both fascinating and fraught with moral peril
FCC Chair Brendan Carr to Testify Before Senate Commerce Committee Amid Disney-ABC Controversy
Gulf Sovereign Funds Unite in Paramount–Skydance Bid for Warner Bros Discovery
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 



